{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:03:58Z","timestamp":1786122238445,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008349","name":"University of Duisburg-Essen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["491780329"],"award-info":[{"award-number":["491780329"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.placenta.2026.06.021","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:55:33Z","timestamp":1782802533000},"page":"229-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Esomeprazole treatment targeting sFLT-1 signaling in preeclampsia improves placental and fetal outcome in mice"],"prefix":"10.1016","volume":"182","author":[{"given":"Beatrix","family":"Reisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilo Valerie","family":"W\u00f6lk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Edinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Kimmig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9506-4581","authenticated-orcid":false,"given":"Alexandra","family":"Gellhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2026.06.021_bib1","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301808R","article-title":"Translation of mechanistic advances in preeclampsia to the clinic: long and winding road","volume":"38","author":"Thadhani","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.placenta.2026.06.021_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103780","article-title":"Clinical tools and biomarkers to predict preeclampsia","volume":"75","author":"MacDonald","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.placenta.2026.06.021_bib3","article-title":"Reconciling the distinct roles of angiogenic\/anti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies","author":"Umapathy","year":"2019","journal-title":"Angiogenesis"},{"key":"10.1016\/j.placenta.2026.06.021_bib4","doi-asserted-by":"crossref","first-page":"S907","DOI":"10.1016\/j.ajog.2020.09.047","article-title":"Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways","volume":"226","author":"Redman","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.06.021_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","article-title":"The two-stage placental model of preeclampsia: an update","volume":"134\u2013135","author":"Staff","year":"2019","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.placenta.2026.06.021_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess Placental Soluble fms-like Hypertension , and Proteinuria in","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.placenta.2026.06.021_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected Preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.placenta.2026.06.021_bib8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.placenta.2026.06.021_bib9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2036.2005.02306.x","article-title":"The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study","volume":"21","author":"Diav-Citrin","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.placenta.2026.06.021_bib10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/ajg.2009.122","article-title":"The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis","volume":"104","author":"Gill","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.placenta.2026.06.021_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/HYPERTENSIONAHA.116.08408","article-title":"Proton pump inhibitors decrease soluble fms-like tyrosine kinase-1 and soluble endoglin secretion, decrease hypertension, and rescue endothelial dysfunction","volume":"69","author":"Onda","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.placenta.2026.06.021_bib12","doi-asserted-by":"crossref","first-page":"388.e1","DOI":"10.1016\/j.ajog.2018.07.019","article-title":"Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trial","volume":"219","author":"Cluver","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2026.06.021_bib13","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/HYPERTENSIONAHA.118.12547","article-title":"Proton pump inhibitors and preeclampsia risk among 157 720 women: a swedish population register-based cohort study","volume":"73","author":"Hastie","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.placenta.2026.06.021_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2024.101478","article-title":"The effects of proton pump inhibitors during pregnancy on treatment of preeclampsia and related outcomes: a systematic review and meta-analysis","volume":"6","author":"Mills","year":"2024","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"10.1016\/j.placenta.2026.06.021_bib15","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/HYPERTENSIONAHA.117.09741","article-title":"Low soluble Fms-Like tyrosine Kinase-1, endoglin, and Endothelin-1 levels in women with confirmed or suspected Preeclampsia using proton pump inhibitors","volume":"70","author":"Saleh","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.placenta.2026.06.021_bib16","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/HYPERTENSIONAHA.121.17567","article-title":"Circulating maternal sFLT1 (soluble fms-Like tyrosine Kinase-1) is sufficient to impair spiral arterial remodeling in a Preeclampsia mouse model","volume":"1","author":"Vogtmann","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.placenta.2026.06.021_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25042040","article-title":"Overexpression of human sFLT1 in the spongiotrophoblast is sufficient to induce placental dysfunction and fetal growth restriction in transgenic mice","volume":"25","author":"Vogtmann","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.placenta.2026.06.021_bib18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-020-01605-x","article-title":"Circulating mRNAs are differentially expressed in pregnancies with severe placental insufficiency and at high risk of stillbirth","volume":"18","author":"Hannan","year":"2020","journal-title":"BMC Med."},{"key":"10.1016\/j.placenta.2026.06.021_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-84785-7","article-title":"DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxia","volume":"11","author":"de Alwis","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.placenta.2026.06.021_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.placenta.2025.12.002","article-title":"Lymphatic mimicry of spiral arteries is impaired by human sFLT1 overexpression in a preeclampsia mouse model","volume":"174","author":"Edinger","year":"2026","journal-title":"Placenta"},{"key":"10.1016\/j.placenta.2026.06.021_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00165","article-title":"Human sFLT1 leads to severe changes in placental differentiation and vascularization in a transgenic hsFLT1\/rtTA FGR mouse model","volume":"10","author":"Vogtmann","year":"2019","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.placenta.2026.06.021_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3024032","article-title":"Systemic maternal human sFLT1 overexpression leads to an impaired foetal brain development of growth-restricted foetuses upon experimental Preeclampsia","volume":"2022","author":"Vogtmann","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.placenta.2026.06.021_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232025","article-title":"Placental defects lead to embryonic lethality in mice lacking the Formin and PCP proteins Daam1 and Daam2","volume":"15","author":"Nakaya","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.placenta.2026.06.021_bib24","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model","volume":"108","author":"Kumasawa","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.placenta.2026.06.021_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158185","article-title":"Actions of esomeprazole on the maternal vasculature in lean and Obese pregnant mice with impaired nitric oxide synthesis: a model of Preeclampsia","volume":"23","author":"de Alwis","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.placenta.2026.06.021_bib26","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1471-0528.2011.02962.x","article-title":"Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia","volume":"118","author":"Whitehead","year":"2011","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.placenta.2026.06.021_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.preghy.2022.07.005","article-title":"Placental DAAM2 is unaltered in preeclampsia, but upregulated by treatment with proton pump inhibitors","volume":"30","author":"de Alwis","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.placenta.2026.06.021_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00441-022-03587-z","article-title":"Esomeprazole inhibits hypoxia\/endothelial dysfunction\u2013induced autophagy in preeclampsia","volume":"388","author":"Gu","year":"2022","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.placenta.2026.06.021_bib29","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis","volume":"59","author":"Stanca Melincovici","year":"2018","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.placenta.2026.06.021_bib30","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13148-015-0120-2","article-title":"The placenta: phenotypic and epigenetic modifications induced by Assisted Reproductive Technologies throughout pregnancy","volume":"7","author":"Choux","year":"2015","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.placenta.2026.06.021_bib31","doi-asserted-by":"crossref","first-page":"R556","DOI":"10.1152\/ajpregu.00192.2022","article-title":"NLRP3 inhibition improves maternal hypertension, inflammation, and vascular dysfunction in response to placental ischemia","volume":"324","author":"Wang","year":"2023","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400426003103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400426003103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:44:13Z","timestamp":1786092253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400426003103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"alternative-id":["S0143400426003103"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2026.06.021","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Esomeprazole treatment targeting sFLT-1 signaling in preeclampsia improves placental and fetal outcome in mice","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2026.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}